Following the departure of Dr. Marcus Wörwag from the management of Wörwag Pharma GmbH & Co. KG, Mr. Jochen Schlindwein will assume management as Managing Director and CEO, starting on December 1, 2019. He will manage the business operations of the Wörwag group together with Mr. Gerhard Mayer, Managing Director and CFO.
For a transition period, also Ms. Monika Wörwag will continue to be part of the Management Board and be responsible for the corporate communications division. The Wörwag family remains responsible for the corporate strategy and will help shape it from within the Advisory Board.
Jochen Schlindwein is a pharmaceutical manager with international experience who most recently worked at Merck as well as Procter & Gamble Consumer Health in Darmstadt. He has broad foreign experience in Eastern European as well as South American markets. Mr. Schlindwein began his pharmaceutical career in the financial sector and later was very successful in his roles as country manager and as regional manager.
Prof. Dr. med. habil. Michael Habs, Head of Advisory Board of the Wörwag Pharma group: “On behalf of the Advisory Board we are pleased to welcome Mr. Schlindwein as new Managing Direcor. Mr. Schlindwein has on many occasions demonstrated that he, with his teams, can achieve results that are well above average. The Advisory Board is convinced that Mr. Schlindwein is an outstanding person for the position of CEO of the Wörwag group and will contribute significantly to the further success of the company. The objective is to lead the Wörwag group to a new level of sales and growth.”
